Global Viral Warts Treatment Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027
Report Code: KNJ1028293 No. of Pages: 133 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Executive Summary
According to GRD Survey data, the global Viral Warts Treatment market was valued at million US$ in 2020 and is expected to reach million US$ by the end of 2027, growing at a CAGR of % in the forecast period between 2021 and 2027.
This report studies the Viral Warts Treatment market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Viral Warts Treatment in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)
Market Snapshot, By Product Type
Injectable
Oral
Market Snapshot, By Application
Hospitals
Homecare
Specialty Clinics
Others
Main Market Players Analyzed in this report, including:
Verrica Pharmaceuticals
Teva Pharmaceutical
Taro Pharmaceutical
Phio Pharmaceuticals
Pfizer
Novan
Mylan
Merck
GlaxoSmithKline
Bausch Health
The study objectives of this report are:
To study and analyze the global Viral Warts Treatment market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Viral Warts Treatment market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Viral Warts Treatment manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Viral Warts Treatment market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Viral Warts Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Viral Warts Treatment are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027
This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries
Table of Contents
1 Market Definition & Scope
1.1 Definition & Scope
1.2 Viral Warts Treatment Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Viral Warts Treatment Market Performance and Outlook
2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter’s Five Forces Analysis
2.3 Comparison of Alternatives and Viral Warts Treatment
3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Viral Warts Treatment Sales Channel and Distributors Analysis
3.3.1 Viral Warts Treatment Sales Channel
3.3.2 Viral Warts Treatment Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Hospitals
3.4.2 Major Buyers in Homecare
3.5 Viral Warts Treatment Manufacturing Cost Structure Analysis
4 Market Segment: by Type
4.1 Viral Warts Treatment Type Introduction
4.1.1 Injectable
4.1.2 Oral
4.2 Global Viral Warts Treatment Sales by Type 2016-2021
4.3 Global Viral Warts Treatment Revenue by Type 2016-2021
4.4 Global Viral Warts Treatment Price by Type 2016-2021
5 Market Segment: by Application
5.1 Viral Warts Treatment Type Introduction
5.1.1 Hospitals
5.1.2 Homecare
5.1.3 Specialty Clinics
5.1.3 Others
5.2 Global Viral Warts Treatment Sales by Application 2016-2021
5.3 Global Viral Warts Treatment Revenue by Application 2016-2021
5.4 Global Viral Warts Treatment Price by Application 2016-2021
6 Marke Segment: by Region
6.1 Global Viral Warts Treatment Market by Region
6.1.1 Global Viral Warts Treatment Sales by Regions
6.1.2 Global Viral Warts Treatment Revenue by Regions
6.2 North America Viral Warts Treatment Market 2016-2021
6.3 Europe Viral Warts Treatment Market 2016-2021
6.4 Asia Pacific Viral Warts Treatment Market 2016-2021
6.5 South America Viral Warts Treatment Market 2016-2021
6.6 Middle East and Africa Viral Warts Treatment Market 2016-2021
7 North America
7.1 North America Viral Warts Treatment Market by Country 2016-2021
7.1.1 North America Viral Warts Treatment Sales by Country
7.1.2 North America Viral Warts Treatment Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico
8 Europe
8.1 Europe Viral Warts Treatment Market by Country 2016-2021
8.1.1 Europe Viral Warts Treatment Sales by Country
8.1.2 Europe Viral Warts Treatment Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain
9 Asia Pacific
9.1 Asia Pacific Viral Warts Treatment Market by Country 2016-2021
9.1.1 Asia Pacific Viral Warts Treatment Sales by Country
9.1.2 Asia Pacific Viral Warts Treatment Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia
10 South America
10.1 South America Viral Warts Treatment Market by Country 2016-2021
10.1.1 South America Viral Warts Treatment Sales by Country
10.1.2 South America Viral Warts Treatment Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia
11 Middle East and Africa
11.1 Middle East and Africa Viral Warts Treatment Market by Country 2016-2021
11.1.1 Middle East and Africa Viral Warts Treatment Sales by Country
11.1.2 Middle East and Africa Viral Warts Treatment Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa
12 Key Participants Company Information
12.1 Verrica Pharmaceuticals
12.1.1 Verrica Pharmaceuticals
Company Information
12.1.2 Verrica Pharmaceuticals
Viral Warts Treatment Product Portfolio, Specification and Application
12.1.3 Verrica Pharmaceuticals
Viral Warts Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Verrica Pharmaceuticals
Key Development
12.2 Teva Pharmaceutical
12.2.1 Teva Pharmaceutical
Company Information
12.2.2 Teva Pharmaceutical
Viral Warts Treatment Product Portfolio, Specification and Application
12.2.3 Teva Pharmaceutical
Viral Warts Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Teva Pharmaceutical
Key Development
12.3 Taro Pharmaceutical
12.3.1 Taro Pharmaceutical
Company Information
12.3.2 Taro Pharmaceutical
Viral Warts Treatment Product Portfolio, Specification and Application
12.3.3 Taro Pharmaceutical
Viral Warts Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Taro Pharmaceutical
Key Development
12.4 Phio Pharmaceuticals
12.4.1 Phio Pharmaceuticals
Company Information
12.4.2 Phio Pharmaceuticals
Viral Warts Treatment Product Portfolio, Specification and Application
12.4.3 Phio Pharmaceuticals
Viral Warts Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Phio Pharmaceuticals
Key Development
12.5 Pfizer
12.5.1 Pfizer
Company Information
12.5.2 Pfizer
Viral Warts Treatment Product Portfolio, Specification and Application
12.5.3 Pfizer
Viral Warts Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Pfizer
Key Development
12.6 Novan
12.6.1 Novan
Company Information
12.6.2 Novan
Viral Warts Treatment Product Portfolio, Specification and Application
12.6.3 Novan
Viral Warts Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Novan
Key Development
12.7 Mylan
12.7.1 Mylan
Company Information
12.7.2 Mylan
Viral Warts Treatment Product Portfolio, Specification and Application
12.7.3 Mylan
Viral Warts Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Novan
Key Development
12.9 GlaxoSmithKline
12.9.1 GlaxoSmithKline
Company Information
12.9.2 GlaxoSmithKline
Viral Warts Treatment Product Portfolio, Specification and Application
12.9.3 GlaxoSmithKline
Viral Warts Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 GlaxoSmithKline
Key Development
12.8 Merck
12.8.1 Merck
Company Information
12.8.2 Merck
Viral Warts Treatment Product Portfolio, Specification and Application
12.8.3 Merck
Viral Warts Treatment Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Merck
Key Development
13 Global Viral Warts Treatment Market Forecast by Region by Type and by Application
13.1 Global Viral Warts Treatment Sales, Revenue Forecast 2022-2027
13.2 Global Viral Warts Treatment Forecast by Regions
13.2.1 Global Viral Warts Treatment Sales Forecast by Region 2022-2027
13.2.2 Global Viral Warts Treatment Revenue Forecast by Region 2022-2027
13.3 Global Viral Warts Treatment Forecast by Type
13.3.1 Global Viral Warts Treatment Sales Forecast by Type 2022-2027
13.3.2 Global Viral Warts Treatment Revenue Forecast by Type 2022-2027
13.3.3 Global Viral Warts Treatment Price Forecast by Type 2022-2027
13.4 Global Viral Warts Treatment Forecast by Application
13.4.1 Global Viral Warts Treatment Sales Forecast by Application 2022-2027
13.4.2 Global Viral Warts Treatment Revenue Forecast by Application 2022-2027
13.4.3 Global Viral Warts Treatment Price Forecast by Application 2022-2027
14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com